TICAGRELOR NOBEL cpr pell 90 mg 168 pce

7680692940049 CH-69294 B01AC24 06.03.2.

Reimbursement limitations:

BRILIQU60.01

En association avec l'acide acétylsalicylique (AAS), indiqué dans la prévention des événements athéro-thrombotiques (décès d'origine …

TICAGRELOR NOBEL cpr pell 90 mg 168 pce
TICAGRELOR NOBEL cpr pell 90 mg 168 pce
TICAGRELOR NOBEL cpr pell 90 mg 168 pce
1 / 3
google

Details

Product number
6929402
CPT
-
Packaging group
3 x 56
Unit
Tablette(n)
Composition
ticagrelorum 90 mg, calcii hydrogenophosphas dihydricus, mannitolum, copovidonum, carboxymethylamylum natricum A, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, E 171, talcum, macrogolum 400, E 172 (flavum), pro compresso obducto corresp. natrium 0.63 mg.

Articles (1)

Ticagrelor NOBEL 90 mg, Filmtabletten
Filmtabletten
3 x 56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
19/03/2025
Professional SmPC
Français
19/03/2025
Professional SmPC
Italien
19/03/2025
Patient information leaflet
Allemand
03/12/2024
Patient information leaflet
Français
03/12/2024
Patient information leaflet
Italien
03/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
90.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
0.63 MG Substance HBESI

Reimbursement information

Public price
CHF 93.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2024

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69294
Drug name
Ticagrelor NOBEL, Filmtabletten
Galenic form
FILM
ATC Code
B01AC24
Authorization status
Z
Dispensation category
B
First authorization
29/08/2024
Authorization expiration date
28/08/2029
IT number
06.03.2.
Domain
Human medicine
Field of application
Thrombozytenaggregationshemmung in Kombination mit Acetylsalicylsäure

Packaging details

Description (FR)
TICAGRELOR NOBEL cpr pell 90 mg 168 pce
Description (DE)
TICAGRELOR NOBEL Filmtabl 90 mg 168 Stk
Market launch
02/12/2024
Narcotic (BTM)
No

Original drug

Brilique, Filmtabletten
CHF 58.40
View original

Other packaging sizes

TICAGRELOR NOBEL cpr pell 60 mg 56 pce
56 TABL
View
TICAGRELOR NOBEL cpr pell 60 mg 168 pce
3 x 56 TABL
View
TICAGRELOR NOBEL cpr pell 90 mg 56 pce
56 TABL
View
TICAGRELOR NOBEL cpr pell 90 mg 98 pce
98 TABL
View